✦ LIBER ✦

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer

✍ Scribed by Hezel, A F; Noel, M S; Allen, J N; Abrams, T A; Yurgelun, M; Faris, J E; Goyal, L; Clark, J W; Blaszkowsky, L S; Murphy, J E; Zheng, H; Khorana, A A; Connolly, G C; Hyrien, O; Baran, A; Herr, M; Ng, K; Sheehan, S; Harris, D J; Regan, E; Borger, D R; Iafrate, A J; Fuchs, C; Ryan, D P; Zhu, A X

Book ID: 125491809
Publisher: Nature Publishing Group
Year: 2014
Tongue: English
Weight: 277 KB
Volume: 111
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2014.343

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab, gemcitabine, and oxaliplatin

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

✍ Birgit Gruenberger; Johannes Schueller; Ute Heubrandtner; Fritz Wrba; Dietmar Ta 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 180 KB

A phase II study of gemcitabine in combi

A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer

✍ Hyun Jung Kim; Nam Su Lee; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Young G 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 347 KB

PEAK: A Randomized, Multicenter Phase II

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer

✍ Schwartzberg, L. S.; Rivera, F.; Karthaus, M.; Fasola, G.; Canon, J.-L.; Hecht, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 520 KB

6618 Results of a multi-center phase II

6618 Results of a multi-center phase II study of imatinib and fluorourcail/leucovorin (FU/LV) in patients with unresectable or metastatic gallbladder or biliary tract cancer

✍ Schuette, K.; Moehler, M.; Kettner, E.; Hegewisch-Becker, S.; Goekkurt, E.; Al-B 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

A phase II trial of gemcitabine and cape

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202

✍ Syma Iqbal; Cathryn Rankin; Heinz-Josef Lenz; Philip J. Gold; Syed A. Ahmad; Ant 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 243 KB

Multicentre phase I–II trial of capecita

Multicentre phase I–II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study

✍ Adalsteinn Gunnlaugsson; Harald Anderson; Pehr Lind; Bengt Glimelius; Anders Joh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 221 KB